Samil Pharmaceutical Co.,Ltd (KRX: 000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,150
+880 (7.17%)
Dec 30, 2024, 3:30 PM KST

Samil Pharmaceutical Co.,Ltd Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
295,09296,901108,894106,418128,907128,479
Upgrade
Market Cap Growth
234.23%-11.01%2.33%-17.45%0.33%2.18%
Upgrade
Enterprise Value
436,420272,367265,842202,048200,995180,425
Upgrade
Last Close Price
13900.006700.007800.007509.099184.439316.22
Upgrade
PE Ratio
-58.25--96.16163.41
Upgrade
PS Ratio
1.090.490.610.791.051.06
Upgrade
PB Ratio
1.680.760.871.622.032.06
Upgrade
P/TBV Ratio
1.960.770.891.652.092.12
Upgrade
P/FCF Ratio
145.07-----
Upgrade
P/OCF Ratio
14.678.2526.2175.1116.5812.13
Upgrade
EV/Sales Ratio
2.051.391.481.511.631.49
Upgrade
EV/EBITDA Ratio
41.4423.0329.5239.5318.7220.48
Upgrade
EV/EBIT Ratio
85.7842.1666.19505.4530.7437.62
Upgrade
EV/FCF Ratio
214.55-----
Upgrade
Debt / Equity Ratio
0.831.381.271.911.491.50
Upgrade
Debt / EBITDA Ratio
13.8014.8717.6824.558.7910.63
Upgrade
Debt / FCF Ratio
71.44-----
Upgrade
Asset Turnover
0.550.540.620.640.660.73
Upgrade
Inventory Turnover
3.984.274.593.533.183.21
Upgrade
Quick Ratio
0.340.220.270.380.480.82
Upgrade
Current Ratio
0.750.480.560.630.731.16
Upgrade
Return on Equity (ROE)
-0.76%1.31%-0.03%-8.27%2.13%1.33%
Upgrade
Return on Assets (ROA)
0.83%1.11%0.86%0.12%2.18%1.81%
Upgrade
Return on Capital (ROIC)
1.00%1.37%1.05%0.14%2.60%2.15%
Upgrade
Earnings Yield
-0.51%1.72%-0.03%-5.02%1.04%0.61%
Upgrade
FCF Yield
0.69%-12.90%-40.71%-29.52%-7.17%-2.57%
Upgrade
Dividend Yield
0.00%---0.74%0.73%
Upgrade
Payout Ratio
0.00%---68.55%77.63%
Upgrade
Buyback Yield / Dilution
7.68%-3.42%-0.82%-2.85%-0.13%-15.56%
Upgrade
Total Shareholder Return
7.68%-3.42%-0.82%-2.85%0.62%-14.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.